Latest

Mpro

Featured Neuroscience Open Neuroscience Articles

·April 25, 2020·3 min read

Novel Compounds Designed To Inhibit SARS-CoV-2 Main Protease

Researchers have developed two new compounds that are able to inhibit SARS-CoV-2 main protease. The study reports one of the compounds is a strong drug candidate for further investigative trials in the treatment of coronavirus.

Featured Neuroscience

·April 11, 2020·3 min read

COVID-19: Six drug candidates identified

Six potential drug candidates have been identified as candidates to treat COVID-19 infections. The drugs, which have previously been subjected to clinical trials for treating a range of conditions, from arthritis to cancer, target Mpro, the main SARS-CoV-2 enzyme.

This shows the structure of the protease

Featured Genetics Neuroscience Open Neuroscience Articles

·March 20, 2020·2 min read

COVID-19: Main protease of SARS-CoV-2 decoded

Researchers have decoded the 3-D architecture of the main SARS-CoV-2 protease. The protein is involved in the reproduction of the virus. The findings may help in the systematic development of drugs to inhibit the reproduction of the virus, potentially lowering COVID-19 infections.